These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19215029)

  • 1. FGF23 is a putative marker for bone healing and regeneration.
    Goebel S; Lienau J; Rammoser U; Seefried L; Wintgens KF; Seufert J; Duda G; Jakob F; Ebert R
    J Orthop Res; 2009 Sep; 27(9):1141-6. PubMed ID: 19215029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of blood vessel formation between standard and delayed bone healing.
    Lienau J; Schmidt-Bleek K; Peters A; Haschke F; Duda GN; Perka C; Bail HJ; Schütze N; Jakob F; Schell H
    J Orthop Res; 2009 Sep; 27(9):1133-40. PubMed ID: 19274756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are bone turnover markers capable of predicting callus consolidation during bone healing?
    Klein P; Bail HJ; Schell H; Michel R; Amthauer H; Bragulla H; Duda GN
    Calcif Tissue Int; 2004 Jul; 75(1):40-9. PubMed ID: 15148561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone as a source of FGF23: regulation by phosphate?
    Mirams M; Robinson BG; Mason RS; Nelson AE
    Bone; 2004 Nov; 35(5):1192-9. PubMed ID: 15542045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal FGF23 levels in adult idiopathic phosphate diabetes.
    Laroche M; Boyer JF; Jahafar H; Allard J; Tack I
    Calcif Tissue Int; 2009 Feb; 84(2):112-7. PubMed ID: 19148564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing.
    Marsell R; Jonsson KB; Cho TJ; Einhorn TA; Ohlsson C; Schipani E
    Acta Orthop; 2007 Feb; 78(1):39-45. PubMed ID: 17453391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic callus formation and craniocerebral trauma: early diagnosis and behavior of basic fibroblast growth factor].
    Wildburger R; Zarkovic N; Petek W; Egger G; Leopold U; Schweighofer F
    Unfallchirurg; 1996 Jan; 99(1):17-23. PubMed ID: 8850075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do serological tissue turnover markers represent callus formation during fracture healing?
    Seebeck P; Bail HJ; Exner C; Schell H; Michel R; Amthauer H; Bragulla H; Duda GN
    Bone; 2005 Nov; 37(5):669-77. PubMed ID: 16126014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum FGF23 concentrations in plasma cell dyscrasias.
    Stewart I; Roddie C; Gill A; Clarkson A; Mirams M; Coyle L; Ward C; Clifton-Bligh P; Robinson BG; Mason RS; Clifton-Bligh RJ
    Bone; 2006 Aug; 39(2):369-76. PubMed ID: 16644301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure, oxygen tension and temperature in the periosteal callus during bone healing--an in vivo study in sheep.
    Epari DR; Lienau J; Schell H; Witt F; Duda GN
    Bone; 2008 Oct; 43(4):734-9. PubMed ID: 18634913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases that associate with and cleave bone morphogenetic protein-2 in vitro are elevated in hypertrophic fracture nonunion tissue.
    Fajardo M; Liu CJ; Ilalov K; Egol KA
    J Orthop Trauma; 2010 Sep; 24(9):557-63. PubMed ID: 20736794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the molecular pathophysiology of delayed bone healing in a sheep model.
    Lienau J; Schmidt-Bleek K; Peters A; Weber H; Bail HJ; Duda GN; Perka C; Schell H
    Tissue Eng Part A; 2010 Jan; 16(1):191-9. PubMed ID: 19678759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of BsALP in healing of long bone fractures.
    Muljacić A; Poljak-Guberina R; Zivković O
    Coll Antropol; 2008 Jun; 32(2):551-6. PubMed ID: 18756909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The systemic angiogenic response during bone healing.
    Weiss S; Zimmermann G; Pufe T; Varoga D; Henle P
    Arch Orthop Trauma Surg; 2009 Jul; 129(7):989-97. PubMed ID: 19037648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic recruitment of osteoblastic cells in fracture healing.
    Shirley D; Marsh D; Jordan G; McQuaid S; Li G
    J Orthop Res; 2005 Sep; 23(5):1013-21. PubMed ID: 16140187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF serum concentrations in patients with long bone fractures: a comparison between impaired and normal fracture healing.
    Sarahrudi K; Thomas A; Braunsteiner T; Wolf H; Vécsei V; Aharinejad S
    J Orthop Res; 2009 Oct; 27(10):1293-7. PubMed ID: 19402151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
    Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
    Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralized tissue cells are a principal source of FGF23.
    Yoshiko Y; Wang H; Minamizaki T; Ijuin C; Yamamoto R; Suemune S; Kozai K; Tanne K; Aubin JE; Maeda N
    Bone; 2007 Jun; 40(6):1565-73. PubMed ID: 17350357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.